US drug approvals
100 approvals with a product on the US market
- Sitagliptin And Metformin Hydrochloride ANDA204144 · approved 4 Jun 2025
- Ibuprofen And Famotidine ANDA203658 · approved 22 Mar 2024
- Topiramate ANDA205976 · approved 4 May 2023
- Adrenalin NDA215875 · approved 21 Apr 2023
- Bismuth Subcitrate Potassium, Metronidazole And Tetracycline Hydrochloride ANDA205770 · approved 6 Mar 2023
Source: Drugs@FDA, Approvals (NDA, ANDA, BLA) held, with a product sold now; newest shown. Retrieved 13 Nov 2026.
